Clinical Trials Logo
  1. Home
  2. Bioequivalence Study
  3. NCT03765944

Bioequivalence Study of NPC-12 (Sirolimus) Granules and Tablets

Bioequivalence Study Clinical Trial

Official title:
A Single Dose, Randomized, Open-label, 2-Period, 2-way Crossover, Bioequivalence Study of Sirolimus Granules and Sirolimus Tablets in Japanese Healthy Adults

Clinical Trial Summary

The purpose of this study is to evaluate the bioequivalece of NPC-12 granules in compare with NPC-12T tablets in Japanese healthy Adults

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03765944
Study type Interventional
Source Nobelpharma
Contact
Status Completed
Phase Phase 1
Start date December 5, 2018
Completion date December 29, 2018
View Details
See also
  Status Clinical Trial Phase
Completed NCT03050164 - Bioequivalence Study of Gefitinib Tablets Under Fasting Conditions Phase 1
Not yet recruiting NCT06441916 - Bioequivalence Study of Dabigatran Etexilate Capsules 150 mg in Healthy Thai Volunteers Under Fasting Conditions Phase 1
Completed NCT04877834 - Bioequivalence Study of DelanzoᵀᴹDR 60mg (Dexlansoprazole) Capsule With Dexilant® 60mg (Dexlansoprazole) Capsule in Healthy Pakistani Subjects. Phase 1
Not yet recruiting NCT06058689 - A Pilot Bioequivalence Study of Pomalidomide Phase 1
Completed NCT05436769 - Bioequivalence Study of Klaribact (Clarithromycin) 500 mg, Film Coated Tablet Phase 1
Completed NCT04585321 - Comparative Bioavailability and Local Tolerability of Two Topical Diclofenac Plasters Applied Once and Twice a Day Phase 1
Completed NCT04873570 - Bioequivalence Study of Mofest® 400mg (Moxifloxacin) Tablet With Avelox® 400mg (Moxifloxacin) Tablet in Healthy Pakistani Subjects Phase 1
Completed NCT01595425 - Bioequivalence Study Comparing D961H Sachet and D961H Capsule in Japanese Healthy Male Subjects Phase 1
Recruiting NCT05794919 - Bioequivalence Study of Calcium Hydroxybenzene Sulphonate Dispersible Tablets in Chinese Healthy Volunteers N/A
Completed NCT04358770 - Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% Cream Phase 1
Completed NCT03602300 - A Phase 1 Bioequivalence Study of a Test Tablet Formulation of Ravidasvir With the Reference Tablet Formulation of Ravidasvir Study Phase 1
Completed NCT05436886 - Bioequivalence Study of Neurogabin-M (Gabapentin 400 mg) Capsule With Parketin (Gabapentin 400 mg) Capsules N/A
Completed NCT01494402 - Study to Assess the Bioequivalence Between D961S and Esomeprazole/Buffered Acetylsalicylic Acid (ASA) in Japanese Healthy Male Subjects Phase 1
Recruiting NCT04229602 - Bioequivalence Study of Venlafaxine Hydrochloride Sustained-Release Capsules in Chinese Healthy Volunteers N/A
Not yet recruiting NCT06273254 - A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions Phase 1